Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO
Status:
Unknown status
Trial end date:
2020-06-18
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of sequential therapy with intravitreal dexamethasone implant
followed by bevacizumab compared with bevacizumab monotherapy for macular edema (ME)
secondary to retinal vein occlusion (RVO).